Navigation Links
Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Sanqi Tablets and Yinqiao Jiedu Tablets
Date:8/13/2009

which we have not previously addressed," Dr. Jiang, Chairman and CEO of Tianyin Pharmaceutical Co., Inc., commented. "We will produce both drugs in our new facility which just passed Sichuan provincial FDA inspection, a key component of GMP certification, in July. We believe the facility meets all GMP standards and we expect to receive certification in the very near term, a milestone which will significantly increase our capacity and enable us to achieve our growth objectives."

About Tianyin Pharmaceuticals

Tianyin is a manufacturer and supplier of modernized Traditional Chinese Medicine ("TCM") in China. It was established in 1994 and acquired by the current management team in August 2003. It has a comprehensive product portfolio of 39 products, 22 of which are listed in the highly selective National Medicine Catalog of the National Medical Insurance program. Tianyin owns and operates two GMP manufacturing facilities and an R&D platform supported by leading Chinese academic institutions. The Company has a pipeline of 40 pharmaceutical products pending approval. Tianyin has an extensive nationwide distribution network throughout China with a sales force of 720 salespeople. Tianyin is headquartered in Chengdu, Sichuan Province with two manufacturing facilities and a total of 1,365 employees. Tianyin achieved revenue of approximately $33.5 million and net income of approximately $6 million in FY2008 ending June 30, 2008. For more information about Tianyin, please visit http://www.tianyinpharma.com .

Safe Harbor Statement

The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements
'/>"/>

SOURCE Tianyin Pharmaceutical Co., Inc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Tianyin Pharmaceutical Co., Inc. Announces Cash Dividend to Common Stockholders
2. Tianyin Pharmaceutical Co., Inc. Adopts New Sales Strategy for Azithromycin Dispersible Tablets
3. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Wednesday, February 18, 2009 at 8:45 a.m. EST
4. Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth
5. Tianyin Pharmaceutical Co., Inc. Announces First Quarter 2009 Financial Results
6. Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:00 p.m. EST
7. Tianyin Pharmaceutical to Present at the Brean Murray All-Cap All-China Conference in New York City on May 20, 2008 at 10:15 a.m. EDT
8. Tianyin Pharmaceutical Announces SFDA Approval to Market Azithromycin Dispersible Tablets
9. Tianyin Pharmaceutical Appoints Three New Independent Board Members
10. Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results
11. Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 2014 Sinovac Biotech Ltd. (Nasdaq: SVA ... China , today announced that it will release its ... 2014, after market close on Thursday, August 14, 2014 EDT. ... market opening on Friday, August 15, 2014, at 8:00 a.m. ... Time) to review the Company,s financial results and provide an ...
(Date:7/24/2014)... OAK RIDGE, Tenn., July 24, 2014 -- A novel ... at the Department of Energy,s Oak Ridge National Laboratory ... known for its unusual physical and electrochemical properties. ... examined how oxygen affects the surface of a perovskite ... electronic behavior. The new avenue to understand surface behavior ...
(Date:7/24/2014)... July 24, 2014  Now available is a stem ... Rehealth Regenerative Therapies , located in Guadalajara, ... active people a new health option: stem cell ... age, countless patients suffer from joint and muscle injuries ... muscle tears, torn rotator cuff, tennis elbow, and knee ...
(Date:7/24/2014)... 24, 2014  ECC West Africa, LLC (ECC) signed ... with University College Hospital (UCH) Ibadan Board of Management ... finance, design, construct, and operate and maintain a new, ... . Under the first of the 4-phase project, ECC ... funding applications. UCH Ibadan intends to finance and develop ...
Breaking Biology Technology:Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results 2ORNL study reveals new characteristics of complex oxide surfaces 2Stem Cells In Sports Injuries, Joints And Muscular Pain 2Stem Cells In Sports Injuries, Joints And Muscular Pain 3ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria 2
... 2011 Nile Therapeutics, Inc. (NASDAQ: ... heart failure patients, today announced that the Company,s securities will ... open of business on May 12, 2011.  The Company expects ... on the OTCQB Marketplace following the suspension of trading on ...
... MOUNTAIN VIEW, Calif., May 11, 2011 ... Biosciences (SBI) , both leaders in genetic modification technology, have ... biotechnology companies involving Transposagen,s piggyBac ™ technology. ... Genetic Modification System enables researchers ...
... 11, 2011 Novavax, Inc. (Nasdaq: NVAX ... by the Tech Council of Maryland (TCM), the largest ... communities of Maryland.  Novavax was recognized as the firm ... community and for its presence and leadership in Maryland. ...
Cached Biology Technology:Nile Therapeutics to Transition to OTCQB Marketplace 2Nile Therapeutics to Transition to OTCQB Marketplace 3Transposagen's piggyBac™ Vectors to be Distributed by System Biosciences 2Transposagen's piggyBac™ Vectors to be Distributed by System Biosciences 3Novavax Named Biotechnology Firm of the Year by Tech Council of Maryland 2
(Date:7/27/2014)... over 18,000 patients, scientists have identified more than ... disease, including six that had not been previously ... , was partially funded by the National Institutes ... in NIH laboratories. , "Unraveling the genetic underpinnings ... mechanisms involved in this complex disease, and hopefully, ...
(Date:7/25/2014)... summer and some of the smoke from those fires is ... by the Moderate Resolution Imaging Spectroradiometer (MODIS) aboard the Aqua ... descended over the Great Lakes region of the United States. ... July 23, 2014 (first image feature highlighted below) clearly shows ... In the image, it is over Manitoba and ...
(Date:7/25/2014)... associate professor of biomedical engineering at the University ... tissue engineering and artificial organ development., "Introduction to ... guide to entering into the field of artificial ... of biomedical engineering at UH, served as a ... while there are other published books on the ...
Breaking Biology News(10 mins):NIH scientists find 6 new genetic risk factors for Parkinson's 2University of Houston researcher publishes textbook on tissue engineering 2
... available in German . Halle/Saale, Potsdam, ... species could lose parts of its current range, a ... Research (UFZ), the Potsdam Institute for Climate Impact Research ... distributions will be rearranged as a result of climate ...
... is no passive spectator of biological processes; it is an ... which the actions of the solvent play a key role. ... has been on observation of the protein backbone and its ... have now been able to detect changes in the proteinwater ...
... to search for food according to how stocked their ... London. When bumblebees return to the nest from ... encourages their nest mates to also go out and ... elicited a standard response from all bees. But new ...
Cached Biology News:Climate change threatens 1 in 5 plant species 2Keeping an eye on the surroundings 2Smells like bees' spirit 2
Mouse monoclonal [0.T.81] to Lac1 ( Abpromise for all tested applications). Antigen: Recombinant TrpE fusion protein containing full length E. coli Lac1....
Peptide-affinity Purified Polyclonal Antibody to ICEBERG Peptide with sequence EEDPQLASKMGLH, from C Terminus of the protein sequence according to NP_067546...
3T3 cells (RSV-transformed) Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
A431 cells stimulated with EGF Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
Biology Products: